COMPOSITIONS CONTAINING AS THE ACTIVE INGREDIENT COMPONENTS FROM SALVIA SCLAREA SEED
The present invention relates to food supplements and nutraceutical compositions for raising omega-3 levels in a subject. Current research in nutritional medicine indicates that the omega-3 fatty acids are essential components of the human diet. According to studies published in the British scientific journal Lancet, the observed low incidence of arteriosclerosis (fatty plaques development on the inner walls of the arteries which obstructs the blood flow), including coronary artery disease, chronic inflammatory disease and diabetes in Greenland Eskimos has been attributed to their traditional ethnic diet, consisting largely of meat from whale, seals, sea birds and fish. This diet is rich in fat and protein and low in carbohydrates, but it is extremely high in omega-3 polyunsaturated fatty acids, and especially rich in two omega-3 fatty acids: C22:6 (DHA) and C20:5 (EPA). The most important omega-3 fatty acids are eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and α-linolenic acid (ALA). EPA is a direct source of an important substance called prostaglandin E3, which is directly responsible for making blood platelets less sticky, thus leading to an easier flow of blood. EPA is, therefore, involved in processes that inhibit blood clots whose presence threaten to obstruct the circulation; this mode of action is particularly important in the small capillaries of the heart. DHA (docosahexaenoic acid) is an omega-3 fatty acid of almost equal importance to EPA. DHA comprises a significant amount of the tissues that make up the human brain as well as a large part of the retina of the eye. Some of the most dramatic effects of increased intake of omega-3 fatty acids are the lowering of high blood pressure, reduction of serum triglyceride levels, and an increase in clotting time, all positive steps in the prevention of heart and blood vessel diseases. These beneficial effects of omega-3 fatty acids have been noted in both clinical trials and epidemiological studies. Omega-3 fatty acids were found to be extremely useful natural substances powerful enough to normalize the high cholesterol and triglyceride levels that are so extensive in modern populations. Omega-3 fatty acids have also been shown to slow down or prevent cancerous tumor growth, prevent blood vessels from closing following vascular surgery, improve inflammatory diseases such as rheumatoid arthritis and relieve symptoms of psoriasis. In addition, omega-3 fatty acids are essential for proper vision and brain development in newborns. The average western diet is low in fresh fish and sea food containing EPA and DHA. On the other hand, it is high in refined carbohydrates and saturated fats. This kind of diet can lead to a serious deficiency in the raw materials necessary for proper platelet function in the blood stream. Linolenic acid is essential for ensuring healthy skin condition. Moreover, oils containing large amounts of omega-3 fatty acids were shown to be effective in preventing skin wrinkles. The ingestion of these oils markedly lowers the cholesterol content in the blood. α-Linolenic acid is a fatty acid found in some plants and can be converted by the body to EPA and DHA. Plant sources of α-linolenic acid include walnuts and walnut oil, flaxseed, rapeseed (used to make canola oil), soybeans, spinach, mustard greens and purslane. α-Linolenic acid is produced in high quantities in several plants, mainly hemp (up to 23% α-linolenic acid is pressed from hempseed) and flax (50%). These oils normally have an “off” flavor and are seldom used as edible oils due to their bad taste and smell. Conventional food oils, such as rapeseed (canola) and soybean contain only small amounts of linolenic acid (11% and 7% respectively). Researchers believe that a 1:1 ratio of omega-6 to omega-3 (omega-6 is found primarily in vegetable oils like corn, safflower or sunflower) may be important in preventing heart disease. It seems that omega-3's and omega-6's continually compete for control of important biochemical reactions in the body. When the portion of omega-6 is higher than that of omega-3, it can lead to an overproduction of hormone-like substances called prostaglandins and leukotrienes. Large amounts of these hormone-like substances can disrupt the immune system, initiate the build-up of plaque formations on artery walls, form blood clots and trigger dangerously irregular heart rhythms. Currently, the ratio in the American diet is about 10 omega-6 to 1 omega-3, a ratio, some experts say, which is a dangerous oversupply of omega-6 fatty acids. Dietary fish oils containing omega-3 fatty acids are increasingly recommended for their antithrombic and hypolipidemic (lowering blood lipid) effects (Phillipson, Rothrock, Connor, Harris and Illingworthm, Omega-3 fatty acids from vegetable oils could provide all the above health benefits without any of the disadvantages of oil from animal source. During ingestion of vegetable oil there is no uptake of cholesterol. Fish oils are a primary source of vitamins A and D. Most marine oils may supply potentially toxic amounts of vitamins A and D, by supplying a sufficient amount of EPA and DHA factors. Also, many vegetal omega-3 oils have a clean flavor have a good taste, at least as compared to bad tasting fish oils. Fish oils are usually contained in preservative-free gelatin capsules for convenience due to their bad taste and smell. Aromatic (essential) oil derived from flowers of No previous use has been made of the seeds of WO 99/62356 concerns enhanced food for humans which has significantly higher omega-3 content by the use of oil obtained from It should be emphasized that the presence of ALA omega-3 fatty acid in oil produced from the seeds of one or another plant does not in itself suffice to indicate that the plant will be a good and effective source for that fatty acid. The range of different parameters, such as commercial cultivability, climatic conditions, regulatory provisions, profile of the fatty acids, percentage of fatty acids, ratio of omega-3 to omega-6, stability, flavor, fragrance, color, acidity, moisture, toxins, allergens, presence of vitamins and antioxidants in the oil, as well as many other parameters, determine whether oil from a certain plant will be a good and effective source for ALA omega-3 fatty acid. Sometimes, one parameter alone, such as aftertaste (e.g. in flax oil or It has now been discovered, surprisingly, that it is possible to produce from the seeds of the plant called clary sage, whose Latin name is Furthermore, the discovery of the unique combination between the fatty acids in the plant (in addition to omega-3 fatty acid, the seeds of this plant are especially rich in oleic acid and other ingredients, and the oil produced contains an optimal ratio between omega-3 and omega-6) and the absence of toxins, including allergens or harmful substances, indicated that this plant could be very advantageously used for the production of a plant oil that could serve as a food supplement. In addition, it was discovered that oil produced from the seeds of The present invention thus embodies numerous advantages, inter alia, in that it enables the production of a nutritional supplement containing omega-3 fatty acid which has a neutral fragrance and taste; is free of toxins, allergens or harmful substances such as heavy metals; tends to oxidize less; and producible in an agrotechnically efficient manner. Moreover, the chemical composition of a nutritional supplement according to the invention embodies a unique combination of fatty acids, minerals and other components, including oleic acid, calcium, fibers and amino acids, the composition and quantities of which could not have been foreseen, as also the optimal ratio between omega-3 and omega-6. Seeds of selected lines of The inventors now disclose that the seed oil of this plant is a rich source of omega-3 α-linolenic acid (about 55%). The other components of this oil are two important fatty acids: oleic acid (C18:1), which is present in extremely high levels, and linoleic acid (C18:2). Both acids are unsaturated fatty acids and are essential in the human diet. The present invention hereby discloses whole seeds, or oil, flour/powder, or pulp obtained from Another important application of this vegetable oil is its use as a drying oil for painting and lubrication, due to its high content of polyunsaturated fatty acids, namely linolenic acid. Up to date, vegetative drying oil has been obtained from crops such as flax seeds and Tong trees. These crops do not lend themselves to mechanical harvesting and cleaning. The prior art discloses (WO 99/62356) oil, rich in omega-3, obtained from The difference between Furthermore, the present invention is based on the realization that not only the oil or crushed flour/powder of Beyond this, the seeds of The present invention is further based on the surprising finding that from among several species of different Thus, the present invention concerns a composition for use as a food supplement comprising, as an active ingredient, a composition of matter selected from: a. b. c. extracts of d. e. The term “composition of matter” refers to several components (fatty acids, proteins, minerals, vitamins, dietary fibers) present as a mixture with specific ratios between the components. The term “ The term “ Examples of manners for separating the oil include:
The term “ The term “ The term “extract of By a preferred embodiment of the present invention, the food supplement consists essentially of: a. b. c. extract of d. e. Preferably, in accordance with a preferred embodiment of the invention, the composition of matter is By a more preferred embodiment of the invention the food supplement consists of: a. b. c. extract of d. e. By one embodiment, the food supplement further comprises a “carrier” suitable for consumption in food products. The carrier is chosen as a carrier known in the art for the specific type of composition of matter of the invention. For example, where the composition of matter of the invention is oil, the carrier may be other types of vegetable oils such as olive oil, rapeseed (canola) oil, corn oil, soy oil, wheat germ oil, coconut oil, peanut oil, sesame oil, palm oil, almond oil, nut, such as walnut, oil, etc. Where the composition of matter of the invention is powder or flour the “carrier” may be other types of flour/powder such as wheat, barley, corn, soy flour, oat flour, rice flour, tapioca, or rye flour. By another possibility, the food supplement contains only one of the ingredients (a-e) above without any “carrier”. The present invention further concerns the use of an agent selected from a. b. c. extracts of d. e. The food supplement above may be used for human or non-human consumption, preferably in order to increase the level of at least one omega-3 fatty acid in the subject. The non-human animal may be a farm animal, such as cattle (cow, goat, and sheep) or poultry (hens, ducks, turkeys), as well as fish grown in fish ponds, such as carp, bass, tilapia, trout, and pond-raised salmon. The food supplement of the present invention is expected to raise the level of at least one omega-3 fatty acid in the meat of the non-human animal (cow, sheep, hens, fish), as well as to raise the level of at least one omega-3 fatty acid in the products of the animals, such as milk and eggs. Thus, the present invention concerns a method for increasing at least one omega-3 fatty acid level in a subject, the method comprising administering to the subject an effective amount of the food supplement of the present invention. The subject may be as defined above and may be a human or non-human animal. The term “effective amount” is an amount that increases the level of at least one omega-3 fatty acid in a statistically significant manner as compared to a control subject not fed with the food supplement of the present invention. The increase in the level of omega-3 fatty acid in the animal may be adjusted in accordance with the type of subject and the desired level, but typically, for example, in egg yolks is an increase of 2- to 10-fold, preferably an increase of more than 4-fold, more preferably an increase of more than 6-fold. By another aspect, the present invention concerns a method for increasing the level of at least one omega-3 fatty acid in egg yolks or in the meat of hens, the method comprising: administering to the hens an effective amount the food supplement of the present invention. The term “effective amount” is as defined above. The present invention further concerns a nutraceutical composition comprising a nutraceutically acceptable carrier and, as an active ingredient, a composition of matter selected from: a. b. c. extracts of d. e. Preferably, the a. b. c. extracts of d. e. The term “nutraceutical composition” refers to any substance that is a food or a part of a food and provides medical or health benefits, including the prevention and treatment of disease or disorder. The present invention further concerns a nutraceutical composition as defined above for the treatment of a disease or a disorder wherein a therapeutically beneficial effect may be evident by increasing the level of at least one omega-3 fatty acid. The term “treatment . . . therapeutically beneficial effect” may refer to at least one of the following: decrease in at least one undesirable effect of the disease; slowing the deterioration caused by the disease; increase in the disease-free time period; or prevention of the disease altogether. Typically, the disease or disorder is selected from: arthrosclerosis, coronary artery disease, chronic inflammatory disease such as rheumatoid arthritis and IBD, diabetes, cancer, prevention of blood vessels from closing after vascular surgery, relieving symptoms of psoriasis, skin wrinkles and depression and mood disorders. The disease may be any disease or condition which is known scientifically, or is discovered empirically, to benefit from the increase in the level of at least one omega-3 fatty acid in the subject. The nutraceutical composition is typically taken orally, for example in the form of gel-capsules containing the oil, liquid formulation containing the oil, tablets containing the flour/powder as known in the art for preparing such compositions, but for several indications, such as psoriasis, and other dermal conditions (wrinkles, dry skin), the oil containing formulations (gel-caps, oil) may also be topically applied. The present invention further concerns a cosmetic composition comprising a cosmetically acceptable carrier and, as an active ingredient, The term “at least one omega-3 fatty acid” refers to any unsaturated fatty acid with its first double bond at the third carbon atom from the methyl-end. These fatty acids may be such as essential fatty acid, α-linoleic acid (ALA) as well as non essential fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). The present invention further concerns a food product comprising the food supplement of the present invention. Examples of food products are as follows:
Omega-3 fatty acids from vegetable oils could provide all the above health and cosmetic benefits without any of the disadvantages of oil from animal sources. Another important aspect of this vegetable oil is its quality as drying oil, for painting and lubrication, due to the high content of polyunsaturated fatty acids, namely linolenic acid. Up to date, vegetative drying oil is obtained from crops such as flax seeds and Tong trees. These crops do not lend themselves to mechanical harvesting and cleaning, as does The Comparative analysis As can be seen the As can be seen, the omega 3:omega 6 ratio in As can be seen, the calcium, potassium and selenium content in the As can been seen, the amino acid contents in 100 g An experiment was conducted to measure the toxicity of 11 kg of 20 hens of the Yarkon variety were selected, having an age of 8.5 months. At termination of the experiment, the hens numbered 18; this is consistent with the standard mortality rate. The laying capacity was approximately 80-90% at the start of the experiment. The hens were fed once or twice daily by hand, so that each hen received approximately 120-130 gr. of feed, as estimated visually. During the first two days, the hens showed classical symptoms seen when feed is changed. These symptoms disappeared thereafter. No change was observed in the quantity of feed consumed by the hens, or in the degree of laying, though these values were not physically measured. The quality of the eggs, their size and breakage levels were not measured, but no change was visibly apparent. At the start of the experiment (Day 1), 10 eggs were selected, refrigerated for 4 days, then their yolks were pooled and sent for chemical analysis. Yolks were refrigerated until analysis was performed. The yolk pool had a volume of 30 ml. The fatty acid content, the Total Fat, and the cholesterol levels were analyzed, and are presented in Table 5 below. On Day 14 of the experiment, 10 additional eggs were selected and their pooled yolks were sent for analysis. On Day 29, 10 yolks were once again pooled and analyzed, and 10 control yolks were likewise pooled and analyzed. The control yolks belong to hens raised in similar conditions; however, the control group did not receive The experiment was discontinued at Day 34. Two hens were then selected, one being a hen in the experiment group, and one control hen. They were slaughtered and their body fat content was analyzed. Results are shown in Table 6 below. In this experiment, the nutritional value of the Referring to Table 5, the percentage of linolenic acid present in the egg contents increased dramatically by 617%. The percentage of DHA increased as well, by 21%. Referring to Table 6, the percentage of linolenic acid present in the body fat of hens that consumed No toxicity was observed for These results demonstrate Based on the nutritional-chemical spectra of analysis, the general conclusions are that According to the analysis shown in tables 1-4 above, it is calculated that 100 grams of 100 grams per day of The The The For production by “cooking extruders,” a dry blend of Formulations for cold extruded pasta products include usage of special natural colorings, dough improvers, spices, flavorings, fibers, etc., that render natural, omega-3 enriched pastas of various shapes and colors. The extruded products can be used as such (without further processing) or mixed with other ingredients for production of health oriented dry or cooked meals, breakfast cereals, granola mixes, etc. Using state-of-the art formulations for cold-extrusion systems omega-3 enriched pasta is obtained in various shapes and colors (using natural colors also with antioxidant activities). The The marinated seeds and also The excess water is then removed by a decanting centrifuge. The omega-3 rich and oleic acid rich oil is collected, blended with natural oxidants, if desired, and bottled as such or blended with other oils (see also Example 8), bottled or blended with other ingredients (emulsifiers, stabilizers, water, etc.) and then homogenized under vacuum to produce high omega-3 and oleic acid butter-like spreads, vegetarian mayonnaise, etc. Additional usage can be to prepare dips such as tehini dip, prepared in conjunction with sesame paste or oil, water, garlic, lemon juice, spices and herbs. The tehini dip can be used as is or made into salad dressings, etc. A sesame/coffee type roaster is used for roasting and controlled temperature heating of the The treated and drained seeds are blended with fish oils, and natural marine flavors omega-3 EPA and DHA fatty acids in desired ratios according to product recipe. The finished product is packed in glass, plastic or metal packaging and processed to render shelf stable or chilled products with long shelf lives. These products are actually described as vegetarian caviar (fish roe) like products with high nutritional values that include all the nutritional factors of In this embodiment, the This embodiment provides sweet water or salty water fish with the entire range of nutritional benefits of The fish formulations are then extruded into floating or sinking pellets according to the type of fish to be fed. The raised fish will contain in their fillets a relatively higher concentration of omega-3 fatty acids, which in turn can be controlled by the concentration of ALA (C18:3) which is also a precursor for natural synthesis of DHA (C22:6) in animal, poultry and fish flesh. These feed formulae contain all typical ingredients and added The ratio of monounsaturated fatty acids to omega-3 fatty acid and omega-6 fatty acid is calculated to be 1 to 1/2 to 1/2, in order to maintain the recommended ratio of 1/3 monousaturated fatty acid, 1/3 polyunsaturated a fatty acid (with a ratio of 1 to 1 between omega-3 fatty acid and omega-6 fatty acid) and 1/3 saturated fatty acids of vegetable or animal origin (such as palm oil, coconut oil, butter, etc.). All fats and oils should be trans-free. The total fats/oil per daily use is calculated to be 60 gr. or 75 gr. (i.e., 27% of diets with 2000 calorie/day or 2500 calorie/day respectively). About 2-3 grams a day of fish oils containing 1000 mg. omega-3 DHA and EPA PUFA, are enclosed separately to the package, in order to supply daily the whole range of omega-3 PUFA: ALA, EPA and DHA. The entire fatty acids/oils daily portion is packed in a 3 compartment package which will include in compartment 1 the fluid oils blend (to be used in salads, cooking, etc.), in compartment 2 a spreadable saturated fatty acids mix (to be used by spreading on crackers, bread slices, etc.) and in compartment 3, the omega-3 PUFA rich, fish oils (to be used with fish salads, dishes, etc., or any other food with a compatible flavor). The fish oil may also be encapsulated. Special oil blends including natural herbal and other antioxidants, and rich in omega-3 and oleic acids may be compounded to yield nutritionally recommended ratios of omega-6:omega-3, mono-unsaturated poly unsaturated and saturated fatty acids. It has been discovered that the To test the stability of This may be compared to the stability reported for Chia oil, such as that reported in Ixtaina et al, “Oxidative Stability of Chia ( This study was carried out in order to probe the extent of oxidative alterations in The magnitude of oxidative changes was monitored by the periodic measurement of peroxide value (PV) (analysis Method-AOCS Cd 8b-90) and free fatty acid (FFA) content, (analysis Method-AOCS Ca 5a-40). A twelve month oil of cold press These results may be contrasted to the PV values for flax seed oil, such as those reported in Hamed and Abo-Elwafa, “Enhancement of oxidation stability of flax seed oil by blending with stable vegetable oils,” See also the peroxide value (PV) for Chia oil as reported in FIG. 4 of Ixtaina (2012), supra. It shows that fresh Chia oil at 20° C. after 195 days has a PV of 20. This may be compared with one year The extremely high stability of The present invention concerns a food supplement comprising Salvia sclarea seeds, or flour, oil or pulp or extracts obtained from the seeds as well as finished food products comprising the food supplement. The present invention further concerns a nutraceutical or cosmetic preparation comprising as an active ingredient Salvia sclarea seeds, or flour, oil or pulp or extracts obtained from the seeds. 1-21. (canceled) 22. A method of preventing wrinkling of skin or ensuring skin health in a subject, comprising:
topically applying to the subject a therapeutically effective amount of a cosmetic composition comprising 23. A therapeutic method of increasing the level of omega-3 fatty acid in a subject, comprising:
administering to the subject a therapeutically effective amount of a product selected from the group consisting of 24. A therapeutic method of treating a subject suffering from a disease or condition which is known scientifically, or is discovered empirically, to benefit from an increase in the level of omega-3 fatty acid, comprising:
orally administering to the subject an effective amount of a product selected from the group consisting of 25. In a method for relieving the symptoms of psoriasis in a subject, comprising topically administering to the affected area of the subject an effective amount of a composition comprising omega-3 fatty acids, the improvement wherein said composition comprises 26. A method in accordance with FIELD OF THE INVENTION
BACKGROUND OF THE INVENTION
SUMMARY OF THE INVENTION
DETAILED DESCRIPTION OF THE INVENTION
General contents Test per 100 g % moisture (g/100 gr) 7.40 7.8 % protein (g/100 gr) 23.38 21.1 % Fat (g/100 gr) 26.20 32.3 % Ash (g/100 gr) 5.77 4.8 % Crude Fiber (g/100 gr) 20.60 27.7 mg/100 g Calcium 0.82-0.928 0.0680 mg/100 g Phosphorus 0.70-0.682 0.780 mg/100 Potassium 1.02-1.29 0.809 g/100 g Dietary fibers 17.80 N/A Saturated fat from total gr. fat 2.50 3.35 Fatty acids contents Range Fatty Acid Range ( ( Profile Myristic Acid C14:0 0.1-0.1 0 Palmitic Acid C16:0 6.6-6.7 6.8-8.0 Palmitoleic Acid C16:1 0.1-0.1 Heptadecanoic Acid C17:0 0.2-0.2 Heptadecenoic Acid C17:1 0.1-0.1 Stearic Acid C18:0 2.8-3.1 1.9-2.6 Oleic Acid C18:1 6.6-7.0 24.7-25.2 Linoleic Acid C18:2 18.6-18.9 12.1-14.8 Linolenic Acid C18:3 (ω − 3) 58.2-59.1 49.9-56.0 Linolenic Acid C18:3 (ω − 6) 0.0-0.1 0-0.2 Arachidic Acid C20:0 0.3-0.3 Gadoleic Acid C20:1 0.1-0.1 0.6 Eicosadienoic Acid C20:2 0.1-0.1 Eicosatrienoic Acid C20:3 (ω − 3) 0.1-0.1 Behenic Acid C22:0 0.1.0.1 0.1 Docosatetraenoic Acid C22:4 0.1-0.1 Lignoceric Acid C24 0.2-0.2 0.1 Total Fat 32.25% 26.2% mineral profile In ( ) the recommended USRDA mg in 100 g seeds (mg) mg/kg mg in 100 g seeds Ag <0.05 AI 2.2 N/A Ag <0.05 <0.01 B 1.4 N/A Ba 2.3 N/A Be <0.01 N/A Ca (1000) 928 679.8 Cd <0.01 0.018 Co <0.05 0.25 Cr 0.03 0.5 Cu (2) 1.9 1.7 Fe 8.4 9.9 Hg 0.07 0.01 K (2500) 1290 809 Li <0.09 N/A Mg (400) 360 380 Mn (4) 4.3 N/A Mo 0.06 0.25 Na 17.3 12.15 Ni <0.05 0.25 p 682 780 Pb <0.05 <0.035 s 261 290 Se (60 μg) 0.06 (60 μg) 1 Sr 2.2 N/A Ti <0.03 N/A V <0.05 N/A Zn 5.6 4.4 amino acid contents Total % Ess. a.a. in Protein Sample 100 g USRDA Compound g/day g/ukg 1 CysO3 1.06 1.82 2 Aspartic 9.65 9.47 3 Met. sulf 0.51 0.45 Threon. 0.5 4 Threonine 3.99 4.25 0.92 (Essential) 5 Serine 5.66 6.02 6 Glutamic 17.64 15.37 7 Proline 3.18 0.73 8 Glycine 6.16 5.23 9 Alanine 5.46 5.34 Val. 0.8 11 Valine (Essential) 5.05 6.32 Meth. 1.1 1.16 12 Methionine 0.51 0.45 Isoleu. 0.7 0.19 (Essential) 13 Isoleucine 3.79 3.98 Leu. 1.1 0.87 (Essential) 14 Leucine 7.78 7.30 1.78 (Essential) 15 Tyrosine 4.19 3.41 Phen. 1.1 16 Phenylalanine 6.32 5.86 N/A 1.45 (Essential) 17 Histidine 2.63 3.19 Lys. 0.8 0.60 (Essential) 18 Lysine (Essential) 3.69 5.50 0.85 19 Gamma N/A arninobuty 20 Arginine 10.71 11.03 2.46 (essential) Total: ≈98% ≈96% Example 1
Effect of
Content of Eggs Produced by Hens after Consumption of Seed Flour % Fatty Acids In Oil Fatty acid Name Control Treated % change C14:0 Myristic 0.37 0.35 — C16:0 Palmitic 24.64 23.36 −6 C16:1 Palmitolic 3.18 3.55 +5 C18:0 Stearic 9.23 7.68 −17 C18:1 Oleic 42.28 43.26 +2 C18:2 Linoleic 15.78 15.51 −2 C18:3 Linolenic 0.57 4.09 +617 C20:5 EPA C22:6 DHA 0.57 0.69 +21 Total fat in the 20.9 23.0 +10 egg (%) P/S ratio 0.47 0.69 +21 Content of Hen Body Fat after Consumption of Seed Flour % Fatty Acids in Oil Fatty acid Name Control Treated % change C14:0 Myristic 0.52 0.54 +4 C16:0 Palmitic 18.84 19.55 +4 C16:1 Palmitolic 3.71 4.70 +27 C18:0 Stearic 5.89 5.51 −6 C18:1 Oleic 37.95 40.88 +8 C18:2 Linoleic 29.75 23.57 −21 C18:3 Linolenic 1.44 3.85 +167 Total hen's fat 55.3 37.6 −32 (%) P/S ratio 1.23 1.07 −7 % S in 14.5 9.93 −32 Triglycerides Example 2
Calculations Concerning
Example 3
Production of
Example 4
Production of Cereals Snacks and Pasta
Example 5
Production of Low-Calorie Baked Goods
Example 6
Production of Oil
Example 7
Production of Paste
Example 8
Production of Omega-3 Enriched Oil Preparations
Example 9
Production of Fish Feed Formulations
Example 10
Production of Packaged or Encapsulated Oil
Example 11
ComparativeSility of
Oil stability (105° C.), hr 6.6 Oil stability (120° C.), hr 2.4 Oil stability (130° C.), hr 0.85 Example 12
Assessment of Oxidative Deterioration of
Shelf life test 1: Glass bottle 250 cc of Sage Oil Batch number: 11AE15 11AE15 11AE15 11AE15 11AE15 11AE15 11AE15 Days at 40° C. 0 30 60 90 120 150 180 acceleration Free fatty acid 0.92 1.03 1.02 1.08 1.13 0.96 0.92 content % as oleic acid (FFA) peroxide 7.4 5 3.7 6.5 3.3 3 7.6 value (PV) (meq/kg) Shelf life test 2: Glass bottle 250 cc of Sage Oil Batch number: 12AE16 12AE16 12AE16 12AE16 12AE16 12AE16 12AE16 Days at 40° C. 0 30 60 90 120 150 180 acceleration Free fatty acid 1.11 1.18 1.21 1.3 1.35 1.37 1.08 content % as oleic acid (FFA) peroxide 6.4 4.6 3.6 6.2 2.7 2.1 6.5 value (PV) (meq/kg) Shelf life test 3: Glass bottle 250 cc of Sage Oil Batch number: 11AE15 11AE15 11AE15 11AE15 11AE15 Days at 25° C. 0 90 123 270 365 Free fatty acid 0.92 0.96 0.96 1.01 1.03 content % as oleic acid (FFA) peroxide 7.4 6 4.9 3.3 3.6 value (PV) (meq/kg) Shelf life test 4: Glass bottle 250 cc of Sage Oil Batch number: 12AE16 12AE16 12AE16 12AE16 12AE16 Days at 25° C. 0 90 123 270 365 Free fatty acid 1.11 1.2 1.13 1.25 1.22 content % as oleic acid (FFA) peroxide 6.4 5.5 4.3 3 2.9 value (PV) (meq/kg) Shelf life test 5: PET bottle 250 cc of Sage Oil Batch number: 11AE15 11AE15 11AE15 11AE15 11AE15 Days at −22° C. 0 90 123 270 365 Free fatty acid 0.92 0.94 0.95 0.91 0.97 content % as oleic acid (FFA) peroxide 7.4 8.1 7.2 5.6 5.7 value (PV) (meq/kg) Shelf life test 6: PET bottle 250 cc of Sage Oil Batch number: 12AE16 12AE16 12AE16 12AE16 12AE16 Days at −22° C. 0 90 123 270 365 Free fatty acid 0.92 1.16 1.09 0.88 1.03 content % as oleic acid (FFA) peroxide 7.4 6.7 6.6 11.7 5.4 value (PV) (meq/kg) Shelf life test 7: Glass bottle 250 cc of Sage Oil Batch number: 11AE15 11AE15 11AE15 Days at 4° C. 0 180 365 Free fatty acid 0.92 0.94 0.96 content % as oleic acid (FFA) peroxide 7.4 7.6 5.3 value (PV) (meq/kg) Shelf life test 8: Glass bottle 250 cc of Sage Oil Batch number: 12AE16 12AE16 12AE16 Days at 4° C. 0 180 365 Free fatty acid 1.11 1.08 1.13 content % as oleic acid (FFA) peroxide 6.4 6.5 4.7 value (PV) (meq/kg)